{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:51:29Z","timestamp":1782532289831,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171950, 81871361"],"award-info":[{"award-number":["82171950, 81871361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"Introduction<\/jats:title>Heart transplantation is the best treatment for end-stage dilated cardiomyopathy (DCM). Left ventricular assist device (LVAD) support is becoming more prevalent and may delay heart transplantation. Gene expression of the left ventricular myocardium usually changes following LVAD implantation. In this study, we aimed to identify potential biomarkers to determine the prognosis of patients with DCM after receiving LVAD support.<\/jats:p><\/jats:sec>Methods<\/jats:title>We extracted microarray datasets from Gene Expression Omnibus (GEO), including GSE430 and GSE21610. There were 28 paired DCM samples in the GSE430 and GSE21610 profiles. Differentially expressed genes (DEGs) were identified at LVAD implantation and heart transplantation. DEGs were annotated according to Gene Ontology (GO) and analyzed according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. A protein\u2013protein interaction (PPI) network was constructed. The top 10 crucial genes were predicted using Cytoscape plugin CytoHubba in conformity with the network degree algorithm. The levels of gene expression and the diagnostic values of crucial genes were confirmed in the clinical datasets.<\/jats:p><\/jats:sec>Results<\/jats:title>The 28 DEGs were clustered into the GSE datasets. GO annotations and KEGG pathway enrichment analyses revealed that inflammation might be involved. They were associated with correlative inflammation. Combined with PPI networks, these results revealed CytoHubba's top 10 hub genes, including CCL2<\/jats:italic>, CXCL12<\/jats:italic>, CXCL1<\/jats:italic>, CTGF<\/jats:italic>\/CCN2<\/jats:italic>, CX3CR1<\/jats:italic>, POSTN<\/jats:italic>, FKBP5<\/jats:italic>, SELE<\/jats:italic>, AIF1<\/jats:italic>, and BMP2<\/jats:italic>. Among them, CCL2<\/jats:italic>, CXCL12<\/jats:italic>, FKBP5<\/jats:italic>, and BMP2<\/jats:italic> might be considered prognostic and diagnostic biomarkers after LVAD support and have confirmed their validity in clinical datasets. The area under the curve of the four main hub genes was more than 0.85, indicating high diagnostic ability and good prognosis for patients with DCM with LVAD implantation. However, a significant effect of CCL2<\/jats:italic>, CXCL12<\/jats:italic>, FKBP5<\/jats:italic>, and BMP2<\/jats:italic> expression was not observed on the left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), cardiac index (CI), or support time of LVAD.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>CCL2<\/jats:italic>, CXCL12<\/jats:italic>, FKBP5<\/jats:italic>, and BMP2<\/jats:italic> could be potential gene biomarkers for patients with DCM after LVAD support. These findings provide critical clues for the therapeutic management of patients with DCM and LVADs. LVEDD, LVEF, CI, and support time of LVAD were not correlated with the expression of these hub genes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1013057","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:38:51Z","timestamp":1679027931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Ying","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/nejm199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5603\/KP.a2019.0027","article-title":"The role of long-term mechanical circulatory support in the treatment of end-stage heart failure","volume":"77","author":"Paluszkiewicz","year":"2019","journal-title":"Kardiol Pol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/ejhf.733","article-title":"Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies","volume":"19","author":"Bellavia","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1152\/physiolgenomics.00022.2003","article-title":"Alterations of gene expression in failing myocardium following left ventricular assist device support","volume":"14","author":"Chen","year":"2003","journal-title":"Physiol Genomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1152\/physiolgenomics.00030.2010","article-title":"Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support","volume":"42","author":"Schwientek","year":"2010","journal-title":"Physiol Genomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","article-title":"TBtools: an integrative toolkit developed for interactive analyses of big biological data","volume":"13","author":"Chen","year":"2020","journal-title":"Mol Plant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"iMeta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","article-title":"STRING: known and predicted protein\u2013protein associations, integrated and transferred across organisms","volume":"33","author":"von Mering","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","article-title":"STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene","volume":"28","author":"Snel","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/s0003-4975(00)01083-3","article-title":"Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation","volume":"69","author":"Bank","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.pbiomolbio.2008.02.002","article-title":"Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process","volume":"97","author":"Klotz","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/HCO.0b013e3282fc7010","article-title":"Left ventricular assist device-induced molecular changes in the failing myocardium","volume":"23","author":"Soppa","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/s0735-1097(03)00043-3","article-title":"Differential gene expression and genomic patient stratification following left ventricular assist device support","volume":"41","author":"Blaxall","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/molbev\/mst080","article-title":"Evidence for polygenic adaptation to pathogens in the human genome","volume":"30","author":"Daub","year":"2013","journal-title":"Mol Biol Evol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cjca.2014.12.006","article-title":"Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices","volume":"31","author":"Grosman-Rimon","year":"2015","journal-title":"Can J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11883-009-0021-y","article-title":"Monocyte chemoattractant protein-1\/CCL2 as a biomarker in acute coronary syndromes","volume":"11","author":"Gonzalez-Quesada","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/aor.13627","article-title":"Effects of left ventricular assist device on heart failure patients: a bioinformatics analysis","volume":"44","author":"Li","year":"2020","journal-title":"Artif Organs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s43032-021-00791-0","article-title":"CXCL12 may drive inflammatory potential in the ovine corpus luteum during implantation","volume":"29","author":"McIntosh","year":"2022","journal-title":"Reprod Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/07853890.2021.1974084","article-title":"Role and implications of the CXCL12\/CXCR4\/CXCR7 axis in atherosclerosis: still a debate","volume":"53","author":"Murad","year":"2021","journal-title":"Ann Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.3748\/wjg.v27.i47.8194","article-title":"Microarray analysis to explore the effect of CXCL12 isoforms in a pancreatic pre-tumor cell model","volume":"27","author":"Miao","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13046-019-1461-z","article-title":"Acetyl-L-carnitine downregulates invasion (CXCR4\/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies","volume":"38","author":"Baci","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/17434440.2016.1243053","article-title":"Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature","volume":"13","author":"Ton","year":"2016","journal-title":"Expert Rev Med Devices"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1073\/pnas.1816847116","article-title":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk","volume":"116","author":"Zannas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12872-021-02146-8","article-title":"Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis","volume":"21","author":"Kolur","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/00365513.2017.1318447","article-title":"Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans","volume":"77","author":"Rutkovskiy","year":"2017","journal-title":"Scand J Clin Lab Investig"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/cells9102179","article-title":"Serum levels of bone morphogenetic proteins 2 and 4 in patients with acute myocardial infarction","volume":"9","author":"Kercheva","year":"2020","journal-title":"Cells"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1013057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:38:55Z","timestamp":1679027935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1013057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2023.1013057"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1013057","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1013057"}}